Erudio Healtherudio.com
Drug
Trametinib trials: what clinicians said in public
No HCP commentary report on a trial studying trametinib yet. Erudio has found public clinician commentary on 5 clinical trials studying trametinib, including CodeBreaK 101, COMBI-AD, NeoTrio and TAPUR. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| TAPUR NCT02693535 · American Society of Clinical Oncology DeepView → | advanced solid tumors, non-Hodgkin lymphoma or multiple myeloma | Phase 2 | Deep | View | |||
| CodeBreaK 101 NCT04185883 · Amgen DeepView → | KRAS G12C-mutated advanced solid tumors | Phase 1 | Deep | View | |||
| COMBI-AD NCT01682083 · Novartis Pharmaceuticals DeepView → | high-risk BRAF V600 mutation-positive melanoma after surgical resection | Phase 3 | Deep | View | |||
| NeoTrio NCT02858921 · Melanoma Institute Australia FocusedView → | BRAF V600-mutant resectable stage III melanoma | Phase 2 | Focused | View | |||
| NCT02034110 NCT02034110 · Novartis Pharmaceuticals FocusedView → | Not given | Phase 2 | Focused | View | |||